HIDAC.pptx

il y a 1 an 4 Vues

Drug dev approval

il y a 2 ans 114 Vues

Role of olaparib in breast and ovarian cancers

il y a 2 ans 689 Vues

RECIST

il y a 2 ans 1228 Vues

Response assessment lymphomas

il y a 2 ans 43 Vues

Part 2 response in lymphomas

il y a 2 ans 98 Vues

lymphoma response

il y a 2 ans 322 Vues

Detection, reporting and monitoring of ad rs final ppt

il y a 2 ans 1227 Vues

phases of a clinical trial and accelerated drug

il y a 2 ans 177 Vues